Add Yahoo as a preferred source to see more of our stories on Google. Michigan State University scientists have built tiny beating heart organoids that can be driven into atrial fibrillation with ...

A blood test clarifies which gene variants truly cause congenital heart defects, linking diagnosis to more precise ...

Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far. A new multi-chamber organoid ...

Tenaya Therapeutics (TNYA) is a very interesting biotech because it is in the process of developing two one-time gene therapies to treat patients with common genetic heart disorders. I believe that ...

An advanced human heart organoid system can be used to model embryonic heart development under pregestational diabetes-like conditions, researchers report. The organoids recapitulate hallmarks of ...

Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far. A new multi-chamber organoid ...

New hope offered by a pharmacy team for treating heart disease by sharing insights into the fundamental process of how the heart is formed in utero. From his lab at the University of Houston College ...

In a study involving data from thousands of people, the risk of a new coronary heart disease diagnosis was statistically ...